CH423766A - Verfahren zum Herstellen wasserlöslicher Verbindungen von Cholinphosphorsäurediglyceridestern - Google Patents
Verfahren zum Herstellen wasserlöslicher Verbindungen von CholinphosphorsäurediglyceridesternInfo
- Publication number
- CH423766A CH423766A CH538261A CH538261A CH423766A CH 423766 A CH423766 A CH 423766A CH 538261 A CH538261 A CH 538261A CH 538261 A CH538261 A CH 538261A CH 423766 A CH423766 A CH 423766A
- Authority
- CH
- Switzerland
- Prior art keywords
- phosphoric acid
- soluble compounds
- preparing water
- acid diglyceride
- diglyceride esters
- Prior art date
Links
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 title 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 title 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 title 1
- 229960001231 choline Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
- C07F9/103—Extraction or purification by physical or chemical treatment of natural phosphatides; Preparation of compositions containing phosphatides of unknown structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEN19273A DE1141639B (de) | 1960-12-05 | 1960-12-05 | Verfahren zur Herstellung wasserloeslicher Cholinphosphorsaeure-diglyceridester-Verbindungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH423766A true CH423766A (de) | 1966-11-15 |
Family
ID=7340822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH538261A CH423766A (de) | 1960-12-05 | 1961-05-08 | Verfahren zum Herstellen wasserlöslicher Verbindungen von Cholinphosphorsäurediglyceridestern |
Country Status (9)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1202370B (it) * | 1976-07-12 | 1989-02-09 | Hoffmann La Roche | Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti |
| DE3047048A1 (de) | 1980-12-13 | 1982-07-29 | A. Nattermann & Cie GmbH, 5000 Köln | Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten |
| DE3229179C2 (de) * | 1982-08-05 | 1986-04-17 | A. Nattermann & Cie GmbH, 5000 Köln | Lungensurfactant |
| US4649155A (en) * | 1983-07-22 | 1987-03-10 | Hoffmann-La Roche Inc. | Injectable solutions |
| US4866044A (en) * | 1985-07-09 | 1989-09-12 | Takeda Chemical Industries, Ltd. | Solubilized composition of poorly-soluble pharmaceutical product |
| JPS62106018A (ja) * | 1985-11-01 | 1987-05-16 | Santen Pharmaceut Co Ltd | 高濃度ビタミンｅ水性製剤 |
| CA1319886C (en) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
| USRE42190E1 (en) | 1998-11-20 | 2011-03-01 | Arena Pharmaceuticals, Inc. | Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors |
| US7816492B2 (en) * | 1998-11-20 | 2010-10-19 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors |
| US20030017528A1 (en) * | 1998-11-20 | 2003-01-23 | Ruoping Chen | Human orphan G protein-coupled receptors |
| ATE348152T1 (de) * | 2000-12-01 | 2007-01-15 | Astellas Pharma Inc | Verfahren zum screening von diabetes- heilverfahren |
| EP1538217A4 (en) * | 2002-09-11 | 2006-09-27 | Astellas Pharma Inc | SCREENING METHOD FOR INSULATION STOP ENHANCER |
| WO2007007982A2 (en) * | 2005-07-07 | 2007-01-18 | Postech Foundation | Glucose uptake modulator and method for treating diabetes or diabetic complications |
| US8314080B2 (en) | 2010-04-06 | 2012-11-20 | Kuwait University | Method of treating type I diabetes |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2055083A (en) * | 1932-07-13 | 1936-09-22 | Winthrop Chem Co Inc | Pharmaceutical preparation |
-
0
- NL NL260444D patent/NL260444A/xx unknown
- BE BE610853D patent/BE610853A/xx unknown
- NL NL126750D patent/NL126750C/xx active
-
1960
- 1960-12-05 DE DEN19273A patent/DE1141639B/de active Pending
-
1961
- 1961-02-06 SE SE1203/61A patent/SE310977B/xx unknown
- 1961-05-08 CH CH538261A patent/CH423766A/de unknown
- 1961-05-18 GB GB18086/61A patent/GB953899A/en not_active Expired
- 1961-06-01 DK DK224361AA patent/DK130619B/da unknown
- 1961-06-02 US US114286A patent/US3197368A/en not_active Expired - Lifetime
- 1961-12-04 FR FR880887A patent/FR1643M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DK130619B (da) | 1975-03-17 |
| GB953899A (en) | 1964-04-02 |
| DK130619C (US20080293856A1-20081127-C00150.png) | 1975-08-25 |
| FR1643M (fr) | 1963-01-07 |
| SE310977B (US20080293856A1-20081127-C00150.png) | 1969-05-19 |
| NL126750C (US20080293856A1-20081127-C00150.png) | |
| BE610853A (US20080293856A1-20081127-C00150.png) | |
| US3197368A (en) | 1965-07-27 |
| NL260444A (US20080293856A1-20081127-C00150.png) | |
| DE1141639B (de) | 1962-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH387004A (de) | Verfahren zur Herstellung von Phosphonsäureestern | |
| CH423766A (de) | Verfahren zum Herstellen wasserlöslicher Verbindungen von Cholinphosphorsäurediglyceridestern | |
| CH441259A (de) | Verfahren zur Herstellung von Phosphorsäureestern | |
| CH400111A (de) | Verfahren zur Herstellung von aliphatischen Phosphatestern | |
| CH358429A (de) | Verfahren zur Herstellung von Dialkyl-thiono-phosphorsäureestern von N-Methylolverbindungen | |
| CH388299A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern | |
| CH335062A (de) | Verfahren zur Herstellung von Derivaten der Phosphorsäure | |
| CH385883A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern | |
| CH378320A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern | |
| CH399441A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern | |
| CH355775A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern | |
| CH387053A (de) | Verfahren zur Herstellung von Thioestern von Phosphorsäure-Derivaten | |
| CH348403A (de) | Verfahren zur Herstellung von Dithiophosphorsäureestern | |
| CH367832A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern | |
| CH420169A (de) | Verfahren zur Herstellung von Phosphorsäureestern | |
| CH368156A (de) | Verfahren zur Herstellung von Phosphorsäureestern | |
| CH399461A (de) | Verfahren zum Herstellen von Phosphon- bzw. Thiophosphonsäureestern | |
| CH368486A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern | |
| CH364773A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern | |
| CH385866A (de) | Verfahren zur Herstellung von Phosphorsäureester-Derivaten | |
| CH390261A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern | |
| CH395395A (de) | Verfahren zur Herstellung von wasserlöslichen Leukoschwefelsäureestersalzen der Anthrachinonreihe | |
| CH387652A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern | |
| CH414597A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern | |
| CH410989A (de) | Verfahren zur Herstellung von Thiophosphorsäureestern |